For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251124:nRSX7729Ia&default-theme=true
RNS Number : 7729I NewRiver REIT PLC 24 November 2025
24 November 2025
NewRiver REIT plc
("NewRiver" or the "Company")
Changes to Directors' Responsibilities
As previously set out in our 2025 Annual Report, Alastair Miller, reached nine
years of service at NewRiver in June 2025. Alastair will remain with us into
2026 so that we can continue to have access to his extensive experience and
guidance. He will now however step down from his roles as Remuneration
Committee Chair, Senior Independent Director and Non-Executive Director
responsible for Workforce Engagement with immediate effect. A search is
underway to appoint a further Non-Executive Director to the NewRiver Board and
an update regarding this will be made in due course.
NewRiver is pleased to announce that Colin Rutherford, independent
Non-Executive Director, is to be appointed Senior Independent Director of the
Company with immediate effect.
We are also pleased to announce that Charlie Parker, independent Non-Executive
Director, will be appointed as Chairman of the Remuneration Committee and
Non-Executive Director responsible for Workforce Engagement at the Company
with immediate effect.
For further information
NewRiver REIT plc +44 (0)20 3328 5800
Kerin Williams (Company Secretary)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOABXBDBRBDDGUS
Copyright 2019 Regulatory News Service, all rights reserved